Privia Health Group, Inc. (PRVA) stock
Close on Nov 11, 2026Market cap $3.07BP/E 92.5Yield –
Privia Health Group, Inc. grew revenue 19.2% to $2.43B over the twelve months to Sep 30, 2026. Operating income rose 80.9% to $51.01M, moving the operating margin from 1.4% to 2.1%. At the latest close the market valued the company at $3.07B, 92.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $3.07B
- P/E ratio
- 92.5
- Price to sales
- 1.26
- Price to book
- 3.76
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.43B
- Net income
- $34.75M
- EPS, diluted
- $0.26
- Book value per share
- $6.15
- Diluted shares
- 133M
Trading
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Previous close
- $24.37
- Open
- $24.37
- Day's range
- $23.98 – $24.71
- Volume
- 821,208
- Average volume (20 days)
- 1,333,843
- Index membership
- S&P SmallCap 600 (since Aug 2023), Russell 2000 (since Jun 2021), Russell 3000 (since May 2021)
- Beta (5 years)
- 0.65
- 52-week range
- $18.91 – $28.82
- RSI (14 days)
- 66.4
- Volatility (1 year)
- 32.6%
- Relative volume
- 0.64×
- WACC
- 8.1%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | PRVA | S&P 500 | Difference | PRVA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.3% | -2.4% | +17.7 pts | ||
| 3 months | +9.4% | -1.2% | +10.5 pts | ||
| Year to date | +1.4% | +12.3% | −10.9 pts | ||
| 1 year | -1.2% | +12.4% | −13.6 pts | ||
| 3 years | +10.3% | +78.8% | −68.5 pts | +3.3% | +21.4% |
| 5 years | -24.7% | +75.2% | −99.9 pts | -5.5% | +11.9% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Privia Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- News
About Privia Health
Services-Health Services
Privia Health Group, Inc. operates as a physician-enablement company that collaborates with healthcare providers, medical practices, health plans, and health systems. The company organizes clinicians into regional medical groups and accountable care organizations to facilitate both fee-for-service medicine and value-based care programs. Its offerings center on a technology platform that integrates clinical workflows, electronic medical records, patient access tools, and telehealth services. Privia Health also provides management services organizations that deliver administrative support, revenue cycle management, clinical analytics, and group purchasing services. Its primary customers include independent physicians, non-physician clinicians, health systems, commercial payers, government programs, and self-insured employers.
Company profile, executives and historyPrivia Health stock: common questions
What is Privia Health's stock price?
PRVA closed at $24.04 on Nov 11, 2026, down 1.35% on the day. Over the past 52 weeks it traded between $18.91 and $28.82.
What is Privia Health's market cap?
Privia Health was worth $3.07B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is PRVA's P/E ratio?
PRVA trades at 92.5 times earnings, based on diluted earnings per share of $0.26 over the twelve months to Sep 30, 2026.
How much revenue does Privia Health make?
Privia Health reported revenue of $2.43B for the twelve months to Sep 30, 2026, up 19.2% from a year earlier.
Does Privia Health pay a dividend?
No. Privia Health has not paid a cash dividend over the last twelve months.
When does Privia Health report earnings next?
Privia Health is expected to report Q4 FY2026 results on Feb 25, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has PRVA stock performed over the past year?
Including dividends, PRVA returned -1.2% over the past year, against +12.4% for the S&P 500.
How many PRVA shares are sold short?
4M shares were sold short at the latest FINRA report, 3.28% of the float, or 4.5 days of average trading volume.
Who are Privia Health's competitors?
Companies most similar to Privia Health by business, industry and size include PIII, LFST, INNV, AGL, PNTG.
See a number that looks wrong?